HUT64068A - Process for producing triaza-spirodecanone methylchroman derivatives and pharmaceutical compositions comprising such compounds - Google Patents
Process for producing triaza-spirodecanone methylchroman derivatives and pharmaceutical compositions comprising such compounds Download PDFInfo
- Publication number
- HUT64068A HUT64068A HU9203382A HU9203382A HUT64068A HU T64068 A HUT64068 A HU T64068A HU 9203382 A HU9203382 A HU 9203382A HU 9203382 A HU9203382 A HU 9203382A HU T64068 A HUT64068 A HU T64068A
- Authority
- HU
- Hungary
- Prior art keywords
- carbon atoms
- straight
- branched alkyl
- hydroxy
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Photoreceptors In Electrophotography (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4135473A DE4135473A1 (de) | 1991-10-28 | 1991-10-28 | Triazaspirodecanon-methylchromane |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9203382D0 HU9203382D0 (en) | 1993-01-28 |
| HUT64068A true HUT64068A (en) | 1993-11-29 |
Family
ID=6443565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9203382A HUT64068A (en) | 1991-10-28 | 1992-10-28 | Process for producing triaza-spirodecanone methylchroman derivatives and pharmaceutical compositions comprising such compounds |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6060482A (2) |
| EP (1) | EP0539803B1 (2) |
| JP (1) | JP3257708B2 (2) |
| KR (1) | KR930007945A (2) |
| AT (1) | ATE175414T1 (2) |
| AU (1) | AU650792B2 (2) |
| CA (1) | CA2081256A1 (2) |
| CZ (1) | CZ322492A3 (2) |
| DE (2) | DE4135473A1 (2) |
| DK (1) | DK0539803T3 (2) |
| ES (1) | ES2125879T3 (2) |
| FI (1) | FI924848A7 (2) |
| GR (1) | GR3029450T3 (2) |
| HU (1) | HUT64068A (2) |
| IL (1) | IL103546A0 (2) |
| MX (1) | MX9205869A (2) |
| NO (1) | NO923974L (2) |
| TW (1) | TW208010B (2) |
| ZA (1) | ZA928290B (2) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19522088A1 (de) * | 1995-06-19 | 1997-01-02 | Bayer Ag | Benzisothiazolyl-substituierte Aminomethylchromane |
| CA2226058C (en) * | 1997-01-30 | 2008-01-29 | F. Hoffmann-La Roche Ag | 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives |
| US6686370B2 (en) * | 1999-12-06 | 2004-02-03 | Euro-Celtique S.A. | Triazospiro compounds having nociceptin receptor affinity |
| JPWO2003040382A1 (ja) * | 2001-11-09 | 2005-03-03 | 株式会社カネカ | 光学活性クロマン誘導体の製造法および中間体 |
| US6995168B2 (en) | 2002-05-31 | 2006-02-07 | Euro-Celtique S.A. | Triazaspiro compounds useful for treating or preventing pain |
| NZ538307A (en) * | 2002-09-09 | 2008-04-30 | Janssen Pharmaceutica Nv | Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
| CA2542626A1 (en) * | 2003-10-16 | 2005-04-21 | William R. Collier | Fluid level detector and alarm apparatus |
| US20060178390A1 (en) * | 2004-08-02 | 2006-08-10 | Alfonzo Jordan | 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
| CN103202840B (zh) * | 2006-11-28 | 2015-02-11 | 詹森药业有限公司 | 3-(3-氨基-2-(r)-羟基-丙基)-1-(4-氟-苯基)-8-(8-甲基-萘-1-基甲基)-1,3,8-三氮杂-螺[4.5]癸烷-4-酮的盐 |
| JP5490677B2 (ja) * | 2007-04-09 | 2014-05-14 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 不安及び鬱病の処置のためのｏｒｌ−１受容体リガンドとしての１，３，８−三置換−１，３，８−トリアザ−スピロ［４．５］デカン−４−オン誘導体 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3826835A (en) * | 1971-01-08 | 1974-07-30 | Ciba Geigy Corp | 8-benzofurylmethyl-1,3,8-triazaspiro(4,5)decanes as neuroleptics |
| US4826848A (en) * | 1985-04-15 | 1989-05-02 | Janssen Pharmaceutica N.V. | Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines |
| US4689330A (en) * | 1985-04-15 | 1987-08-25 | Janssen Pharmaceutica N.V. | Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines |
| US4749702A (en) * | 1985-04-15 | 1988-06-07 | Janssen Pharmaceutica N. V. | Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines |
| US4957928A (en) * | 1986-06-26 | 1990-09-18 | Ciba-Geigy Corporation | Hydrogenated 1-benzooxacycloalkylpyridinecarboxylic acid compounds |
| DE3901814A1 (de) * | 1988-07-28 | 1990-02-01 | Bayer Ag | Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga |
| DE3831888A1 (de) * | 1988-09-20 | 1990-03-29 | Troponwerke Gmbh & Co Kg | Arzneimittel zur behandlung von apoplexia cerebri |
| DE4039631A1 (de) * | 1990-12-12 | 1992-06-17 | Troponwerke Gmbh & Co Kg | Neuroprotektive kombination |
-
1991
- 1991-10-28 DE DE4135473A patent/DE4135473A1/de not_active Withdrawn
-
1992
- 1992-09-26 TW TW081107641A patent/TW208010B/zh active
- 1992-10-07 AU AU26265/92A patent/AU650792B2/en not_active Ceased
- 1992-10-13 MX MX9205869A patent/MX9205869A/es unknown
- 1992-10-13 NO NO92923974A patent/NO923974L/no unknown
- 1992-10-15 DK DK92117606T patent/DK0539803T3/da active
- 1992-10-15 EP EP92117606A patent/EP0539803B1/de not_active Expired - Lifetime
- 1992-10-15 DE DE59209607T patent/DE59209607D1/de not_active Expired - Fee Related
- 1992-10-15 AT AT92117606T patent/ATE175414T1/de not_active IP Right Cessation
- 1992-10-15 ES ES92117606T patent/ES2125879T3/es not_active Expired - Lifetime
- 1992-10-19 US US07/963,165 patent/US6060482A/en not_active Expired - Fee Related
- 1992-10-23 CA CA002081256A patent/CA2081256A1/en not_active Abandoned
- 1992-10-26 CZ CS923224A patent/CZ322492A3/cs unknown
- 1992-10-26 FI FI924848A patent/FI924848A7/fi unknown
- 1992-10-26 IL IL103546A patent/IL103546A0/xx unknown
- 1992-10-27 KR KR1019920019792A patent/KR930007945A/ko not_active Withdrawn
- 1992-10-27 ZA ZA928290A patent/ZA928290B/xx unknown
- 1992-10-28 HU HU9203382A patent/HUT64068A/hu unknown
- 1992-10-28 JP JP31279892A patent/JP3257708B2/ja not_active Expired - Fee Related
-
1999
- 1999-02-19 GR GR990400535T patent/GR3029450T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2626592A (en) | 1993-04-29 |
| KR930007945A (ko) | 1993-05-20 |
| CZ322492A3 (en) | 1993-07-14 |
| ES2125879T3 (es) | 1999-03-16 |
| DK0539803T3 (da) | 1999-08-30 |
| MX9205869A (es) | 1993-04-01 |
| NO923974L (no) | 1993-04-29 |
| EP0539803A1 (de) | 1993-05-05 |
| EP0539803B1 (de) | 1999-01-07 |
| GR3029450T3 (en) | 1999-05-28 |
| ATE175414T1 (de) | 1999-01-15 |
| TW208010B (2) | 1993-06-21 |
| DE59209607D1 (de) | 1999-02-18 |
| FI924848A7 (fi) | 1993-04-29 |
| JPH05222040A (ja) | 1993-08-31 |
| IL103546A0 (en) | 1993-03-15 |
| HU9203382D0 (en) | 1993-01-28 |
| FI924848A0 (fi) | 1992-10-26 |
| DE4135473A1 (de) | 1993-04-29 |
| US6060482A (en) | 2000-05-09 |
| ZA928290B (en) | 1993-05-04 |
| CA2081256A1 (en) | 1993-04-29 |
| JP3257708B2 (ja) | 2002-02-18 |
| AU650792B2 (en) | 1994-06-30 |
| NO923974D0 (no) | 1992-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT65427A (en) | Process for preparation of azaheterocyclyl-methyl-chromane derivatives and pharmaceuticals compositions containing them | |
| JP3299321B2 (ja) | ２−アミノメチル−クロマン類 | |
| HUT64068A (en) | Process for producing triaza-spirodecanone methylchroman derivatives and pharmaceutical compositions comprising such compounds | |
| HUT74618A (en) | Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives for producing pharmaceutical compositions suitable for treatment of central nervous system and new substituted 4-phenyl-6-amino-nikotinic-acid | |
| HU198713B (en) | Process for producing ergolin derivatives and pharmaceutical compositions containing them as active components | |
| JPH10504820A (ja) | Ｎ−置換されたフェノチアジン類の使用 | |
| HUT65525A (en) | Process for preparation of piperidyl-methyl-substituted chromane derivatives and pharmaceuticals containing them | |
| WO2014020101A1 (fr) | Derives de griseofulvine | |
| HU218209B (hu) | 2,3-Ciklikusan kondenzált 1,4-dihidro-piridin-származékok alkalmazása a központi idegrendszer kezelésére alkalmas gyógyszerkészítmények előállítására | |
| EP2066677B1 (en) | Pyridooxazepine progesteron receptor modulators | |
| DE3520104C2 (de) | Naphthoxazine, ihre Herstellung und Verwendung | |
| IL91015A (en) | Pharmaceutical compositions for the treatment of obstructive functional disorders of the lungs and/or disorders of the efferent urinary passages, containing substituted 3,4-dihydro-2h-benzopyrans | |
| RU2164915C2 (ru) | Производные 4н-пирана, смесь их изомеров, отдельные изомеры и их соли | |
| JPH09169764A (ja) | ２−（アミノメチル）−３，４，７，９−テトラヒドロ−２Ｈ−ピラノ［２，３−ｅ］インドール−８−オンおよびその誘導体 | |
| HU201006B (en) | Process for producing thioformamide derivatives and pharmaceutical compositions comprising same as active ingredient | |
| HU187140B (en) | Process for preparing new aburnan-oxima ethers | |
| HU224425B1 (hu) | (5R)-(Metilamino)-5,6-dihidro-4H-imidazo[4,5,1-ij]-kinolin-2(1H)-on előállítása során alkalmazható heterociklusos intermedierek | |
| KR19990024927A (ko) | 옥사졸리디논 유도체 및 그의 제조방법 및 항균제 조성물 | |
| KR100530016B1 (ko) | 옥사졸리디논 유도체 및 이의 제조방법 및 그를 함유하는항균제 조성물 | |
| HU215594B (hu) | Ciklohexadiénszármazékok, ezeket tartalmazó gyógyszerkészítmények, és eljárás a vegyületek előállítására | |
| HU187139B (en) | Process for preparing new eburnan derivatives | |
| JPH08208653A (ja) | アクリルアミド誘導体及びその製造方法 | |
| JPS6313996B2 (2) | ||
| HU219239B (en) | Piperidinyl substituted methanoanthracenes, process for producing them and pharmaceutical compositions containing them | |
| FR2548668A1 (fr) | Derives d'hexahydro-indolo-naphtyridines, leur preparation et leur application en therapeutique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFA9 | Temporary protection cancelled due to abandonment |